Bank of Montreal Can Has $34.38 Million Stock Position in The Clorox Company (NYSE:CLX)

Bank of Montreal Can lowered its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 18.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 210,363 shares of the company's stock after selling 47,483 shares during the quarter. Bank of Montreal Can owned 0.17% of Clorox worth $34,378,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. Prospera Private Wealth LLC acquired a new position in Clorox in the 3rd quarter valued at approximately $27,000. Innealta Capital LLC acquired a new position in Clorox in the 2nd quarter valued at approximately $30,000. Trifecta Capital Advisors LLC increased its stake in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock valued at $30,000 after buying an additional 130 shares during the period. Family Firm Inc. acquired a new position in Clorox in the 2nd quarter valued at approximately $31,000. Finally, Quarry LP increased its stake in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company's stock valued at $31,000 after buying an additional 114 shares during the period. Institutional investors and hedge funds own 78.53% of the company's stock.

Analysts Set New Price Targets

CLX has been the topic of several research reports. DA Davidson upped their price objective on shares of Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research note on Monday, November 4th. TD Cowen upgraded shares of Clorox from a "sell" rating to a "hold" rating and upped their price objective for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. JPMorgan Chase & Co. increased their price target on shares of Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a research note on Friday, October 11th. Citigroup increased their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Finally, Barclays increased their price target on shares of Clorox from $137.00 to $139.00 and gave the stock an "underweight" rating in a research note on Friday, November 1st. Five investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $155.00.

Insider Transactions at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the firm's stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares of the company's stock, valued at approximately $2,229,719.92. This trade represents a 11.40 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.57% of the stock is owned by insiders.

Clorox Stock Performance

Clorox stock traded up $0.02 during mid-day trading on Friday, reaching $167.17. The company had a trading volume of 465,384 shares, compared to its average volume of 1,238,729. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.35. The company has a 50 day moving average of $163.02 and a 200-day moving average of $149.14. The firm has a market cap of $20.69 billion, a price-to-earnings ratio of 57.87, a PEG ratio of 3.09 and a beta of 0.41.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the firm earned $0.49 EPS. The business's revenue was up 27.0% on a year-over-year basis. On average, sell-side analysts expect that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.92%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox's payout ratio is 170.04%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.